KR880001651A - 이미다조 [4,5-b] 피리딘 유도체, 그의 제조방법 및 그를 함유하는 항궤양제 - Google Patents

이미다조 [4,5-b] 피리딘 유도체, 그의 제조방법 및 그를 함유하는 항궤양제 Download PDF

Info

Publication number
KR880001651A
KR880001651A KR1019870008092A KR870008092A KR880001651A KR 880001651 A KR880001651 A KR 880001651A KR 1019870008092 A KR1019870008092 A KR 1019870008092A KR 870008092 A KR870008092 A KR 870008092A KR 880001651 A KR880001651 A KR 880001651A
Authority
KR
South Korea
Prior art keywords
group
imidazo
carbon atoms
hydrogen atom
same
Prior art date
Application number
KR1019870008092A
Other languages
English (en)
Other versions
KR940002824B1 (ko
Inventor
나오또 마쓰이시
하루끼 다께다
겐이찌 이이즈미
기요까즈 무라까미
아끼라 히사미쯔
Original Assignee
노베고지
도오꾜 다나베세이야꾸 가부시끼 가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 노베고지, 도오꾜 다나베세이야꾸 가부시끼 가이샤 filed Critical 노베고지
Publication of KR880001651A publication Critical patent/KR880001651A/ko
Application granted granted Critical
Publication of KR940002824B1 publication Critical patent/KR940002824B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

이미다조 〔4,5-b〕피리딘 유도체, 그의 제조방법 및 그를 함유하는 항궤양제
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (3)

  1. 하기 일반식(Ⅰ)로 표시되는 이미다조 〔4,5-b〕피리딘 유도체.
    (상기식에서, R1은 환상알킬기로서 치환되어 있어도 좋은 탄소수 1~8개의 직쇄상 혹은 분지상의 알콕시기 또는 탄소수 2~4개의 플루오로알킬옥시기를 나타내며, R2는 수소원자, 메틸기 또는 메톡시기를 나타내고, R3및 R4는 같거나 다르며, 각각 수소원자 또는 메틸기를 나타낸다)
  2. 하기 일반식(Ⅱ)으로 표시되는 술피드 화합물을 산화시켜 얻어지는 하기 일반식(Ⅰ)로 표시되는 이미다조 〔4,5-b〕피리딘 유도체의 제조방법.
    (상기식에서, R1은 환상알킬기로서 치환되어 있어도 좋은 탄소수 1~8개의 직쇄상 혹은 분지상의 알콕시기 또는 탄소수 2~4개의 플루오로알킬옥시기를 나타내며, R2는 수소원자, 메틸기 또는 메톡시기를 나타내고, R3및 R4는 같거나 다르며, 각각 수소원자 또는 메틸기를 나타낸다)
  3. 하기 일반식(Ⅰ)로 표시되는 이미다조 〔4,5-b〕피리딘 유도체를 유효성분으로 하는 항궤양제.
    (상기식에서, R1은 환상알킬기로서 치환되어 있어도 좋은 탄소수 1~8개의 직쇄상 혹은 분지상의 알콕시기 또는 탄소수 2~4개의 플루오로알킬옥시기를 나타내며, R2는 수소원자, 메틸기 또는 메톡시기를 나타내고, R3및 R4는 같거나 다르며, 각각 수소원자 또는 메틸기를 나타낸다)
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019870008092A 1986-07-25 1987-07-24 이미다조[4,5-b]피리딘 유도체 및 그의 제조방법 KR940002824B1 (ko)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP173551 1986-07-25
JP17355186 1986-07-25
JP173551/86 1986-07-25
JP62133534A JPH0643426B2 (ja) 1986-07-25 1987-05-30 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
JP133534 1987-05-30
JP133534/87 1987-05-30

Publications (2)

Publication Number Publication Date
KR880001651A true KR880001651A (ko) 1988-04-25
KR940002824B1 KR940002824B1 (ko) 1994-04-04

Family

ID=26467860

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019870008092A KR940002824B1 (ko) 1986-07-25 1987-07-24 이미다조[4,5-b]피리딘 유도체 및 그의 제조방법

Country Status (14)

Country Link
US (1) US4808596A (ko)
EP (1) EP0254588B1 (ko)
JP (1) JPH0643426B2 (ko)
KR (1) KR940002824B1 (ko)
AR (1) AR245718A1 (ko)
AT (1) ATE71626T1 (ko)
AU (1) AU598564B2 (ko)
CA (1) CA1329204C (ko)
DE (1) DE3776018D1 (ko)
ES (1) ES2038184T3 (ko)
GR (1) GR3003777T3 (ko)
HU (1) HU200458B (ko)
MX (1) MX168756B (ko)
ZA (1) ZA875151B (ko)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71664A (en) * 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
EP0187977B1 (en) * 1984-12-18 1990-08-29 Otsuka Pharmaceutical Co., Ltd. Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same
KR950001015B1 (ko) * 1986-01-10 1995-02-07 닛뽕 케미화 가부시끼가이샤 술폭시드 유도체의 제조방법
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2679745B2 (ja) * 1989-06-29 1997-11-19 明治製菓株式会社 アゾール誘導体及びそれらを有効成分とする抗潰瘍剤
US5200407A (en) * 1989-06-29 1993-04-06 Meiji Seika Kaburhiki Kaisha Azole derivatives and anti-ulcerative composition containing same
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
NZ244301A (en) * 1991-09-20 1994-08-26 Merck & Co Inc Preparation of 2-pyridylmethylsulphinylbenzimidazole and pyridoimidazole derivatives from the corresponding sulphenyl compounds
PT711282E (pt) * 1993-07-28 2002-11-29 Aventis Pharma Ltd Compostos inibidores de pde iv e de fnt
US6051570A (en) * 1997-05-30 2000-04-18 Dr. Reddy's Research Foundation Benzimidazole derivatives as antiulcer agents, process for their preparation and pharmaceutical compositions containing them
AU4387799A (en) * 1998-06-26 2000-01-17 Russinsky Limited Pyridine building blocks as intermediates in the synthesis of pharmaceutically active compounds
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
DE10140492A1 (de) 2001-08-17 2003-08-14 Gruenenthal Gmbh Hydrate von gegebenenfalls substituierten 2-(2-Pyridinyl)methylthio-1H-benzimidazolen und Verfahren zu ihrer Herstellung
JP4634144B2 (ja) * 2002-08-01 2011-02-16 ニコックス エスエー ニトロソ化プロトンポンプ阻害剤、組成物および使用方法
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
FR2845915B1 (fr) 2002-10-21 2006-06-23 Negma Gild Utilisation du tenatoprazole pour le traitement du reflux gastro-oesophagien
FR2845916B1 (fr) * 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un antagoniste des recepteurs h2 a l'histamine
FR2845917B1 (fr) 2002-10-21 2006-07-07 Negma Gild Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire
FR2848555B1 (fr) 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004074285A1 (en) * 2003-02-24 2004-09-02 Mitsubishi Pharma Corporation The enantiomer of tenatoprazole and the use thereof in therapy
WO2004080487A1 (ja) * 2003-03-13 2004-09-23 Eisai Co. Ltd. 歯ぎしりの予防剤または治療剤
US20050031700A1 (en) * 2003-07-18 2005-02-10 Sanatarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP2007522217A (ja) * 2004-02-10 2007-08-09 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤および非ステロイド系抗炎症薬の組み合わせ
JP2007532677A (ja) * 2004-04-16 2007-11-15 サンタラス インコーポレイティッド プロトンポンプ阻害剤、緩衝剤、および運動促進薬の組み合わせ
TW200606163A (en) * 2004-04-22 2006-02-16 Eisai Co Ltd Imidazopyridine compound
CA2563808A1 (en) * 2004-04-28 2005-11-10 Altana Pharma Ag Dialkoxy-imidazopyridines derivatives
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TW200613301A (en) * 2004-06-15 2006-05-01 Altana Pharma Ag Novel amino-halogen-imidazopyridines
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
CN100364989C (zh) * 2004-09-30 2008-01-30 江苏豪森药业股份有限公司 拉唑类衍生物及其盐和用途
EP1824850A2 (en) * 2004-12-09 2007-08-29 Nycomed GmbH SUBSTITUTED IMIDAZO[4,5-b]PYRIDINES AS INHIBITORS OF GASTRIC ACID SECRETION
US20070015782A1 (en) 2005-04-15 2007-01-18 Eisai Co., Ltd. Benzimidazole compound
US9040564B2 (en) 2005-04-28 2015-05-26 Eisai R&D Management Co., Ltd. Stabilized composition
AU2006274036B2 (en) * 2005-07-26 2012-05-24 Takeda Gmbh Isotopically substituted proton pump inhibitors
US7601737B2 (en) 2005-07-26 2009-10-13 Nycomed Gmbh Isotopically substituted proton pump inhibitors
CN1982311B (zh) * 2005-12-13 2010-10-13 天津维智精细化工有限公司 2-巯基-5-甲氧基咪唑[4,5-b]并吡啶的合成工艺
CN100376574C (zh) * 2006-06-14 2008-03-26 浙江大学 泰妥拉唑的制备方法
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
EP2068841B1 (en) 2006-10-05 2018-09-26 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
FR2909380B1 (fr) * 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
CN101497616B (zh) * 2008-01-30 2011-05-18 山东轩竹医药科技有限公司 含有氨基氧基取代的吡啶的咪唑并吡啶的化合物
EP2252274A4 (en) 2008-02-20 2011-05-11 Univ Missouri COMPOSITION COMPRISING A COMBINATION OF OMEPRAZOLE AND LANSOPRAZOLE, AND A BUFFER AGENT, AND METHODS OF USING THE SAME
WO2012004802A1 (en) 2009-07-07 2012-01-12 Council Of Scientific & Industrial Research Continuous flow process for the preparation of sulphoxide compounds
WO2013108068A1 (en) 2012-01-21 2013-07-25 Jubilant Life Sciences Limited Process for the preparation of 2-pyridinylmethylsulfinyl benzimidazoles, their analogs and optically active enantiomers
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (ko) * 1968-10-21 1971-06-03
IL71664A (en) * 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
JPS6034956A (ja) * 1983-08-04 1985-02-22 Fujisawa Pharmaceut Co Ltd 新規チアゾリウム化合物およびその製造法
EP0187977B1 (en) * 1984-12-18 1990-08-29 Otsuka Pharmaceutical Co., Ltd. Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same
KR950001015B1 (ko) * 1986-01-10 1995-02-07 닛뽕 케미화 가부시끼가이샤 술폭시드 유도체의 제조방법
JPS62207271A (ja) * 1986-03-06 1987-09-11 Yamanouchi Pharmaceut Co Ltd ２−ピリジルメチルチオ基または２−ピリジルメチルスルフイニル基で置換された縮合環化合物
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono

Also Published As

Publication number Publication date
AU7562887A (en) 1988-01-28
ES2038184T3 (es) 1993-07-16
KR940002824B1 (ko) 1994-04-04
AU598564B2 (en) 1990-06-28
US4808596A (en) 1989-02-28
HU200458B (en) 1990-06-28
GR3003777T3 (ko) 1993-03-16
JPH0643426B2 (ja) 1994-06-08
JPS63146882A (ja) 1988-06-18
EP0254588A1 (en) 1988-01-27
ZA875151B (en) 1988-01-21
DE3776018D1 (de) 1992-02-27
CA1329204C (en) 1994-05-03
EP0254588B1 (en) 1992-01-15
AR245718A1 (es) 1994-02-28
MX168756B (es) 1993-06-07
HUT46000A (en) 1988-09-28
ATE71626T1 (de) 1992-02-15

Similar Documents

Publication Publication Date Title
KR880001651A (ko) 이미다조 [4,5-b] 피리딘 유도체, 그의 제조방법 및 그를 함유하는 항궤양제
KR870002125A (ko) 피리딘 유도체의 제조방법
KR890005084A (ko) 퀴놀린 유도체
KR860700250A (ko) 신규 아미딘 화합물
ES2046229T3 (es) Composicion antiulcerosa.
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
AU578395B2 (en) Antiallergic 5-alkyl-1-phenyl-2-piperazinoalkyl-pyrazoline- 3-one compounds
KR880011155A (ko) 이미다조피리딘유도체, 그의 제법 및 치료에의 응용
KR870001214A (ko) 4,7-디히드로티에노[2,3-b]피리딘 유도체의 제조방법
KR890014536A (ko) 축합 퀴놀린계 화합물, 축합 아크리딘계 화합물 및 그의 제조방법과 그것을 함유하는 항암제 조성물
KR860003201A (ko) 톨루엔디아민 조성물
CA2234284A1 (fr) Composes a base de silicium biologiquement actif sous forme solide
KR870004038A (ko) 제초제 화합물의 제조방법
KR830001900A (ko) 페닐모르판과 그의 중간물질및 제조방법
KR890008151A (ko) 키놀린 카르복산의 유도체
KR850002979A (ko) 1,2,3-트리티안화합물의 신규 제조방법
KR850001663A (ko) 살충 및 응애류 박멸제 조성물
KR850006180A (ko) 디아미노피리딘의 제조방법
KR890700584A (ko) 헤테로아릴카르복시아미드 유도체 그의 제조방법 및 그것을 함유하는 의약조성물
KR870010070A (ko) 모라노린 유도체의 제조법
KR890004994A (ko) 신규 백금 착화합물
KR880006177A (ko) 구아니디노 메틸벤조산 유도체
KR940019714A (ko) 신규한 벤즈이미다졸 유도체
KR860008184A (ko) 디옥솔로벤조이소옥사졸 유도체의 제법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20080328

Year of fee payment: 15

EXPY Expiration of term